Device
Lotrafilcon A contact lenses
Lotrafilcon A contact lenses is a medical device with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Phase Distribution
Ph phase_4
1
17%
Ph not_applicable
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completed
Air Optix® Night and Day® Aqua Therapeutic Wear
NCT05956535
completed
Air Optix® Night and Day® Aqua Continuous Wear
NCT05992675
completed
Air Optix® Night and Day® Aqua Daily Wear
NCT05976750
completed
AONDA Therapeutic Indication Study I
NCT05891106
completedphase_4
Daily Wear Corneal Infiltrative Event Study
NCT00937105
Clinical Trials (6)
Showing 6 of 6 trials
NCT05956535
Air Optix® Night and Day® Aqua Therapeutic Wear
NCT05992675
Air Optix® Night and Day® Aqua Continuous Wear
NCT05976750
Air Optix® Night and Day® Aqua Daily Wear
NCT05891106
AONDA Therapeutic Indication Study I
NCT00937105Phase 4
Daily Wear Corneal Infiltrative Event Study
NCT01482312Not Applicable
Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6